FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., authorizing changes to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Plaque Psoriasis
• Seborrheic Dermatitis

Drugs mentioned

• BETAMETHASONE DIPROPIONATE (Betamethasone dipropionate)

Snippet

SUPPL AP for BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)